id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-267389-v2ihhtl0	Canevelli, Marco	The Pipeline of Therapeutics Testing During the Emergency Phase of the COVID-19 Outbreak	2020-09-24		.txt	text/plain	3090	136	39	The clinicaltrials.gov database and the European Union (EU) Clinical Trials Register were investigated on March 31, 2020, to identify all ongoing phase 1–4 research protocols testing pharmacological interventions targeting SARS-CoV-2 infection and/or clinical syndromes associated with COVID-19. In this article, we provide a summary of the interventional studies that have been conducted worldwide to test the efficacy and/or safety/tolerability of pharmacological compounds against COVID-19 in the emergency phase of the pandemic. The following data were abstracted by three authors (F.T., Ga.R., and Gi.R.) from the selected protocols: NCT (the unique identification code assigned by clinicaltrials.gov) and/or EudraCT codes; study phase; allocation and masking procedures; tested compound(s); way of administration; mechanism of action; primary outcome measure(s); expected primary completion date; expected number of participants; age range of participants; targeted COVID-19 related condition; sponsor; and location.	./cache/cord-267389-v2ihhtl0.txt	./txt/cord-267389-v2ihhtl0.txt